NPS Pharmaceuticals Inc (NPSP)

45.97
0.01 0.02
Prev Close 45.96
Open 45.96
Day Low/High 45.95 / 45.99
52 Wk Low/High 22.11 / 46.01
Volume 9.49M
Avg Volume 4.75M
Exchange
Shares Outstanding 108.58M
Market Cap 4.99B
EPS -0.08
Div & Yield N.A. (N.A)
NPS Pharma Hormone Drug Wins Shaky Endorsement From FDA Panel

NPS Pharma Hormone Drug Wins Shaky Endorsement From FDA Panel

NPS Pharmaceuticals shares are weak Monday following a rough outing for its hormone replacement therapy Natpara at an FDA advisory panel on Friday.

FDA Advisory Committee Recommends Approval of Natpara® for Long-Term Treatment of Hypoparathyroidism

FDA Advisory Committee Recommends Approval of Natpara® for Long-Term Treatment of Hypoparathyroidism

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the U.

NPS Pharma Stock Trading Halted Today; FDA Advisory Committee To Review Natpara® Biologics License Application

NPS Pharma Stock Trading Halted Today; FDA Advisory Committee To Review Natpara® Biologics License Application

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that NASDAQ has halted trading of...

Perilous Reversal Watch: NPS Pharmaceuticals (NPSP)

Perilous Reversal Watch: NPS Pharmaceuticals (NPSP)

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "perilous reversal" (up big yesterday but down big today) candidate

NPS Pharmaceuticals Larger Than S&P 500 Component Graham Holdings

NPS Pharmaceuticals Larger Than S&P 500 Component Graham Holdings

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component NPS Pharmaceuticals Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Graham Holdings Co.

Why NPS Pharmaceuticals (NPSP) Stock is Surging Today

Why NPS Pharmaceuticals (NPSP) Stock is Surging Today

Shares of NPS Pharmaceuticals (NPSP) soared in afternoon trading Wednesday after the FDA said Natpara decreased the need for calcium and vitamin D supplements in clinical trials.

Heavy Volume And Pre-Market Movement For NPS Pharmaceuticals (NPSP)

Heavy Volume And Pre-Market Movement For NPS Pharmaceuticals (NPSP)

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a pre-market mover with heavy volume candidate

FDA Posts Briefing Materials For Advisory Committee Meeting Reviewing Natpara® For Hypoparathyroidism

FDA Posts Briefing Materials For Advisory Committee Meeting Reviewing Natpara® For Hypoparathyroidism

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the U.

NPS Pharmaceuticals (NPSP) Stock: Weak On High Volume Today

NPS Pharmaceuticals (NPSP) Stock: Weak On High Volume Today

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a weak on high relative volume candidate

Your September Biotech Back-to-School Calendar

Your September Biotech Back-to-School Calendar

The biotech sector hews close to an academic calendar and September marks the start of the busy, event-filled push into the end of the year.

NPS Pharma Reports Second-Quarter 2014 Financial Results

NPS Pharma Reports Second-Quarter 2014 Financial Results

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering innovative therapies that transform the lives of patients with rare diseases, today reported its results for the...

NPS Pharma To Present At Upcoming Conferences

NPS Pharma To Present At Upcoming Conferences

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the Wedbush Securities Life Sciences Management Access Conference in New York on Tuesday, August 12, 2014 at 2:30 p.

3 Stocks Moving The Health Care Sector Upward

3 Stocks Moving The Health Care Sector Upward

TheStreet highlights 3 stocks pushing the health care sector higher today.

NPS Pharma Initiates Phase 2a Study Of NPSP795 In Adult Patients With Autosomal Dominant Hypocalcemia (ADH)

NPS Pharma Initiates Phase 2a Study Of NPSP795 In Adult Patients With Autosomal Dominant Hypocalcemia (ADH)

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, has initiated a Phase 2a study to evaluate the...

NPS Pharma To Report Second Quarter 2014 Financial Results

NPS Pharma To Report Second Quarter 2014 Financial Results

NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) announced today that it will report its second 2014 financial results on Wednesday, August 6, 2014 at approximately 4:30 p.

PARADOX Findings Published In Endocrine Practice Describe High Burden Of Illness In Patients With Hypoparathyroidism

PARADOX Findings Published In Endocrine Practice Describe High Burden Of Illness In Patients With Hypoparathyroidism

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that published results from ...

'Fast Money' Recap: Fear Gauge Retreats but Be Cautious

'Fast Money' Recap: Fear Gauge Retreats but Be Cautious

The trading panel discussed Friday's rally and what they'll be buying and selling next week.

14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014

14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014

Healthcare investors (and traders) have had a lot to work with so far this year, and the next six months promises to be equally action packed.

NPSP Makes Notable Cross Below Critical Moving Average

NPSP Makes Notable Cross Below Critical Moving Average

In trading on Tuesday, shares of NPS Pharmaceuticals Inc. crossed below their 200 day moving average of $30.34, changing hands as low as $30.09 per share.

FDA Approves Updated Labeling For Gattex® (Teduglutide [rDNA Origin]) For Injection To Include Long-Term Data

FDA Approves Updated Labeling For Gattex® (Teduglutide [rDNA Origin]) For Injection To Include Long-Term Data

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the U.

NPS Pharma Reports Change In Tentative Date Of FDA Advisory Committee Review Of Natpara® BLA To September 12 - PDUFA Date Of October 24 Remains Unchanged

NPS Pharma Reports Change In Tentative Date Of FDA Advisory Committee Review Of Natpara® BLA To September 12 - PDUFA Date Of October 24 Remains Unchanged

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today reported that the U.

NPS Pharma To Present At Goldman Sachs Global Healthcare Conference

NPS Pharma To Present At Goldman Sachs Global Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Goldman Sachs 35 th Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Tuesday, June 10, 2014 at 2:00 p.

Apple Conference? Forget It. Biotech Is What Really Matters: StockTwits

Apple Conference? Forget It. Biotech Is What Really Matters: StockTwits

These biotechs are making big waves, as Apple's Worldwide Developers Conference will likely be a washout.

Why NPS Pharmaceuticals (NPSP) Stock Is Surging Today

Why NPS Pharmaceuticals (NPSP) Stock Is Surging Today

NPS Pharmaceuticals (NPSP) surged Monday amid reports that Shire would take over the biopharmaceutical company.

NPS Pharmaceuticals (NPSP) Moving On Heavy Pre-Market Trading

NPS Pharmaceuticals (NPSP) Moving On Heavy Pre-Market Trading

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a pre-market mover with heavy volume candidate

3 Stocks Raising The Drugs Industry Higher

3 Stocks Raising The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Barbarian At The Gate: NPS Pharmaceuticals (NPSP)

Barbarian At The Gate: NPS Pharmaceuticals (NPSP)

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

NPS Pharma Introduces Emergency Resources Kit For Patients In Recognition Of World Hypoparathyroidism Awareness Day

NPS Pharma Introduces Emergency Resources Kit For Patients In Recognition Of World Hypoparathyroidism Awareness Day

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced its support for World ...

NPS Pharma Celebrates 20th Anniversary Of Initial Public Offering With NASDAQ Opening Bell Ceremony

NPS Pharma Celebrates 20th Anniversary Of Initial Public Offering With NASDAQ Opening Bell Ceremony

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that senior management, company...

NPS Pharma To Present At Jefferies Global Healthcare Conference

NPS Pharma To Present At Jefferies Global Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the Jefferies 2014 Global Healthcare Conference in New York on Monday, June 2, 2014 at 11:30 a.